Analysts expect Integra Lifesciences Holdings Corp to report revenue of 393.06 M for Q4 26, against a range of 359.98 M to 426.14 M. The most recent reported quarter, Q3 26, came in at 411.18 M, a 2.8% miss against the 423.11 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 442.64 M | 382.65 M | 415.61 M | 402.06 M | 434.93 M | 391.92 M | 418.76 M | 411.18 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 449.06 M | 430.34 M | 424.86 M | 457.15 M | 440.96 M | 406.56 M | 446.80 M | 452.06 M | 426.14 M | 382.13 M | 455.47 M | 466.84 M | 502.13 M | 407.82 M | 461.45 M | 501.55 M | |||||||||
| Low Estimate | 399.55 M | 375.65 M | 347.77 M | 393.27 M | 369.36 M | 373.52 M | 420.35 M | 394.17 M | 359.98 M | 345.53 M | 421.55 M | 426.69 M | 424.10 M | 357.91 M | 384.34 M | 435.48 M | |||||||||
| Consensus Estimate | 424.30 M | 403.00 M | 386.32 M | 425.21 M | 405.16 M | 390.04 M | 433.57 M | 423.11 M | 393.06 M | 363.83 M | 438.51 M | 446.77 M | 463.12 M | 382.86 M | 422.90 M | 468.52 M |
Analysts expect Integra Lifesciences Holdings Corp to report earnings per share of 0.62 for Q4 26, against a range of 0.59 to 0.65. The most recent reported quarter, Q3 26, came in at 0.59 , in line with the 0.59 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.97 | 0.41 | 0.45 | 0.54 | 0.83 | 0.54 | 0.56 | 0.59 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 0.90 | 0.48 | 0.44 | 0.43 | 0.80 | 0.39 | 0.46 | 0.63 | 0.65 | 0.57 | 0.61 | 0.65 | 0.75 | 0.54 | 0.69 | 0.68 | |||||||||
| Low Estimate | 0.76 | 0.44 | 0.40 | 0.37 | 0.70 | 0.37 | 0.44 | 0.55 | 0.59 | 0.47 | 0.53 | 0.59 | 0.65 | 0.48 | 0.59 | 0.56 | |||||||||
| Consensus Estimate | 0.83 | 0.46 | 0.42 | 0.40 | 0.75 | 0.38 | 0.45 | 0.59 | 0.62 | 0.52 | 0.57 | 0.62 | 0.70 | 0.51 | 0.64 | 0.62 |
Pull Wall Street consensus for Integra Lifesciences Holdings Corp (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=IART&mode=revenue&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "IART", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/estimates?ticker=IART&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();